drugset / Trial / NCT00648310

Topical Oestrogens and Antimuscarinics In The Treatment Of Detrusor Overactivity

NCT00648310 ↗

Phase 2/3 Completed University of Insubria

Summary

Despite the great number of reports about the efficacy of oestrogens or antimuscarinics on OAB symptoms, so far no author has tried to investigate whether the concomitant administration of these two drugs, acting on two different pathophysiological mechanisms, could have a synergic effect reducing the rate of non-responders to treatment.

Timeline

Start
2004-01
Primary completion
—
Completion
2007-12

Outcome

Missed primary endpoint

paper There was no significant difference between the two groups in terms of efficacy of therapy: 80.6% in group 1 versus 82% in group 2 (p=0.86). PMID 18584946 ↗

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tolterodine Unknown 4 mg —
Subject oestriol Unknown — Topical

Indications